Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04261075 |
| Title | IPH5201 as Monotherapy or in Combination With Durvalumab +/- Oleclumab in Subjects With Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MedImmune LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA | ESP | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Huntersville | North Carolina | 28078 | United States | Details | |
| Research Site | Providence | Rhode Island | 02906 | United States | Details | |
| Research Site | Nashville | Tennessee | 37203 | United States | Details | |
| Research Site | Bordeaux Cedex | 33076 | France | Details | ||
| Research Site | Villejuif | 94805 | France | Details | ||
| Research Site | Barcelona | 8035 | Spain | Details | ||
| Research Site | Madrid | 28027 | Spain | Details | ||
| Research Site | Lausanne | 1011 | Switzerland | Details |